OBJECTIVE: To study atherosclerosis regression in mice after plasma lipid reduction to moderately elevated apolipoprotein B (apoB)-lipoprotein levels. APPROACH AND RESULTS: Chow-fed hypomorphic Apoe mice deficient in low-density lipoprotein receptor expression (Apoe(h/h)Ldlr(-/-)Mx1-cre mice) develop hyperlipidemia and atherosclerosis. These mice were studied before and after inducible cre-mediated Apoe gene repair. By 1 week, induced mice displayed a 2-fold reduction in plasma cholesterol and triglyceride levels and a decrease in the non-high-density lipoprotein:high-density lipoprotein-cholesterol ratio from 87%:13% to 60%:40%. This halted atherosclerotic lesion growth and promoted macrophage loss and accumulation of thick collagen fibers for up to 8 weeks. Concomitantly, blood Ly-6C(high) monocytes were decreased by 2-fold but lesional macrophage apoptosis was unchanged. The expression of several genes involved in extracellular matrix remodeling and cell migration was changed in lesional macrophages 1 week after Apoe gene repair. However, mRNA levels of numerous genes involved in cholesterol efflux and inflammation were not significantly changed at this time point. CONCLUSIONS: Restoring apoE expression in Apoe(h/h)Ldlr(-/-)Mx1-cre mice resulted in lesion stabilization in the context of a human-like ratio of non-high-density lipoprotein:high-density lipoprotein-cholesterol. Our data suggest that macrophage loss derived in part from reduced blood Ly-6C(high) monocytes levels and genetic reprogramming of lesional macrophages.
OBJECTIVE: To study atherosclerosis regression in mice after plasma lipid reduction to moderately elevated apolipoprotein B (apoB)-lipoprotein levels. APPROACH AND RESULTS: Chow-fed hypomorphic Apoemice deficient in low-density lipoprotein receptor expression (Apoe(h/h)Ldlr(-/-)Mx1-cre mice) develop hyperlipidemia and atherosclerosis. These mice were studied before and after inducible cre-mediated Apoe gene repair. By 1 week, induced mice displayed a 2-fold reduction in plasma cholesterol and triglyceride levels and a decrease in the non-high-density lipoprotein:high-density lipoprotein-cholesterol ratio from 87%:13% to 60%:40%. This halted atherosclerotic lesion growth and promoted macrophage loss and accumulation of thick collagen fibers for up to 8 weeks. Concomitantly, blood Ly-6C(high) monocytes were decreased by 2-fold but lesional macrophage apoptosis was unchanged. The expression of several genes involved in extracellular matrix remodeling and cell migration was changed in lesional macrophages 1 week after Apoe gene repair. However, mRNA levels of numerous genes involved in cholesterol efflux and inflammation were not significantly changed at this time point. CONCLUSIONS: Restoring apoE expression in Apoe(h/h)Ldlr(-/-)Mx1-cre mice resulted in lesion stabilization in the context of a human-like ratio of non-high-density lipoprotein:high-density lipoprotein-cholesterol. Our data suggest that macrophage loss derived in part from reduced blood Ly-6C(high) monocytes levels and genetic reprogramming of lesional macrophages.
Authors: R K Tangirala; D Praticó; G A FitzGerald; S Chun; K Tsukamoto; C Maugeais; D C Usher; E Puré; D J Rader Journal: J Biol Chem Date: 2001-01-05 Impact factor: 5.157
Authors: Jonathan E Feig; James X Rong; Raanan Shamir; Marie Sanson; Yuliya Vengrenyuk; Jianhua Liu; Katey Rayner; Kathryn Moore; Michael Garabedian; Edward A Fisher Journal: Proc Natl Acad Sci U S A Date: 2011-04-11 Impact factor: 11.205
Authors: Nathalie Gaudreault; Nikit Kumar; Jessica M Posada; Kyle B Stephens; Nabora Soledad Reyes de Mochel; Delphine Eberlé; Victor R Olivas; Roy Y Kim; Matthew J Harms; Sean Johnson; Louis M Messina; Joseph H Rapp; Robert L Raffai Journal: Arterioscler Thromb Vasc Biol Date: 2011-11-03 Impact factor: 8.311
Authors: Ying Zhao; Dan Ye; Jun Wang; Laura Calpe-Berdiel; Saaleha B R N Azzis; Theo J C Van Berkel; Miranda Van Eck Journal: Am J Pathol Date: 2011-07-08 Impact factor: 4.307
Authors: Andrew J Murphy; Mani Akhtari; Sonia Tolani; Tamara Pagler; Nora Bijl; Chao-Ling Kuo; Mi Wang; Marie Sanson; Sandra Abramowicz; Carrie Welch; Andrea E Bochem; Jan Albert Kuivenhoven; Laurent Yvan-Charvet; Alan R Tall Journal: J Clin Invest Date: 2011-10 Impact factor: 14.808
Authors: Stephane Potteaux; Emmanuel L Gautier; Susan B Hutchison; Nico van Rooijen; Daniel J Rader; Michael J Thomas; Mary G Sorci-Thomas; Gwendalyn J Randolph Journal: J Clin Invest Date: 2011-04-18 Impact factor: 14.808
Authors: J X Rong; J Li; E D Reis; R P Choudhury; H M Dansky; V I Elmalem; J T Fallon; J L Breslow; E A Fisher Journal: Circulation Date: 2001-11-13 Impact factor: 29.690
Authors: Mary Y Chang; Christina K Chan; Kathleen R Braun; Pattie S Green; Kevin D O'Brien; Alan Chait; Anthony J Day; Thomas N Wight Journal: J Biol Chem Date: 2012-02-20 Impact factor: 5.157
Authors: Guanying Wang; Roy Y Kim; Isabella Imhof; Norman Honbo; Fu Sang Luk; Kang Li; Nikit Kumar; Bo-Qing Zhu; Delphine Eberlé; Daniel Ching; Joel S Karliner; Robert L Raffai Journal: J Cardiovasc Pharmacol Date: 2014-02 Impact factor: 3.105
Authors: Carla S Ceron; Celine Baligand; Sunil Joshi; Shaynah Wanga; Patrick M Cowley; Joy P Walker; Sang Heon Song; Rajeev Mahimkar; Anthony J Baker; Robert L Raffai; Zhen J Wang; David H Lovett Journal: Am J Physiol Renal Physiol Date: 2017-03-22
Authors: Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai Journal: J Cardiovasc Pharmacol Date: 2016-01 Impact factor: 3.105